Developing training for Data Safety Monitoring Board members: A National Institute of Allergy and Infectious Diseases case study
- PMID: 26152835
- PMCID: PMC4643382
- DOI: 10.1177/1740774515591498
Developing training for Data Safety Monitoring Board members: A National Institute of Allergy and Infectious Diseases case study
Abstract
Background: Data Safety Monitoring Boards primarily review accumulating data on clinical trials and provide recommendations to sponsors on whether a protocol should continue as planned, be modified, or be terminated. Data Safety Monitoring Boards often provide their recommendations based upon accumulating data to which only their members are given access. Despite the substantial responsibilities assumed by Data Safety Monitoring Board members, there is limited information in the literature about the unique knowledge they must possess and, consequently, the training content needs that are required in order for them to fulfill their obligations.
Purpose: This article describes how the National Institute of Allergy and Infectious Diseases identified the knowledge that Data Safety Monitoring Board members should acquire and the computer-based training they developed to address the learning needs of the National Institute of Allergy and Infectious Diseases assembled Data Safety Monitoring Board members.
Methods: The National Institute of Allergy and Infectious Diseases conducted a comprehensive literature search and interviewed Data Safety Monitoring Board subject matter experts, including Data Safety Monitoring Board members and chairs from academic institutions, pharmaceutical companies, and the National Institutes of Health to (1) assess whether Data Safety Monitoring Board training is an identified need, (2) evaluate whether Data Safety Monitoring Board training has been developed, and (3) formulate suitable learning objectives. Data Safety Monitoring Board training modules were developed based on the identified learning objectives identified from the interviews.
Results: Three Data Safety Monitoring Board training modules were developed and formatted for web-based access, which is free of charge to the public at https://dsmblearningcenter.niaid.nih.gov. The modules include the following: an introduction to the objectives and purpose of Data Safety Monitoring Boards, the organization and responsibilities of Data Safety Monitoring Boards, and a review of statistical topics.
Limitations: The complex concepts that Data Safety Monitoring Board members must apply to their deliberations and decisions require practice and application that come through hands-on experience. To build competency in the Data Safety Monitoring Board member role, not only does a member need to understand these complex concepts but also the member must have the opportunity to practice and apply this knowledge to real-life situations. Additional resources to facilitate practice and application of the complex issues that Data Safety Monitoring Boards deal with should be considered. The computer-based training is targeted to new and inexperienced Data Safety Monitoring Board members. Ongoing learning opportunities should be developed for experienced Data Safety Monitoring Board members. Non-English training must also be considered.
Conclusion: The National Institute of Allergy and Infectious Diseases identified that training is not widely available for Data Safety Monitoring Board members to build the unique knowledge and skills necessary to serve on Data Safety Monitoring Boards. Consequently, National Institute of Allergy and Infectious Diseases developed publicly available web-based Data Safety Monitoring Board training modules for new or inexperienced members. Additional tools and resources are needed to help Data Safety Monitoring Board members acquire the knowledge and skills to serve their critical function in clinical research and to maximize research participant protections.
Keywords: DSMB training; publicly available DSMB member resources; web-based modules.
© The Author(s) 2015.
Similar articles
-
Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials.Clin Trials. 2011 Dec;8(6):727-35. doi: 10.1177/1740774511425181. Epub 2011 Oct 24. Clin Trials. 2011. PMID: 22024105
-
Evidence Brief: The Effectiveness Of Mandatory Computer-Based Trainings On Government Ethics, Workplace Harassment, Or Privacy And Information Security-Related Topics [Internet].Washington (DC): Department of Veterans Affairs (US); 2014 May. Washington (DC): Department of Veterans Affairs (US); 2014 May. PMID: 27606391 Free Books & Documents. Review.
-
American Society of Clinical Oncology policy statement: oversight of clinical research.J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29. J Clin Oncol. 2003. PMID: 12721281
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O).Clin Infect Dis. 2021 Dec 6;73(11):2126-2130. doi: 10.1093/cid/ciab239. Clin Infect Dis. 2021. PMID: 33758912 Free PMC article.
-
"You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study.PLoS One. 2018 Jul 26;13(7):e0201037. doi: 10.1371/journal.pone.0201037. eCollection 2018. PLoS One. 2018. PMID: 30048484 Free PMC article.
-
Interim monitoring in a treatment strategy trial with a composite primary endpoint.Contemp Clin Trials. 2019 Nov;86:105846. doi: 10.1016/j.cct.2019.105846. Epub 2019 Sep 11. Contemp Clin Trials. 2019. PMID: 31520741 Free PMC article. Clinical Trial.
-
Data Safety and Monitoring Boards Should Be Required for Both Early- and Late-Phase Clinical Trials.JACC Basic Transl Sci. 2021 Nov 22;6(11):887-896. doi: 10.1016/j.jacbts.2021.09.005. eCollection 2021 Nov. JACC Basic Transl Sci. 2021. PMID: 34869954 Free PMC article.
-
The evolving role of data & safety monitoring boards for real-world clinical trials.J Clin Transl Sci. 2023 Aug 2;7(1):e179. doi: 10.1017/cts.2023.582. eCollection 2023. J Clin Transl Sci. 2023. PMID: 37745930 Free PMC article.
References
-
- Armstrong PW, Califf RM. Data and safety monitoring boards: academic credit where credit is due? JAMA. 2013;310:1563–1564. - PubMed
-
- Sydes MR, Spiegelhalter DJ, Altman DG, et al. Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials. Clin Trials. 2004;1:60–79. - PubMed
-
- DAMOCLES Study Group and NHS Health Technology Assessment Programme A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet. 2005;365(9460):711–722. - PubMed
-
- Ellenberg SS, Fleming TR, DeMets DL. Data monitoring committees in clinical trials: a practical perspective. John Wiley & Sons Ltd; Chichester: 2002.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources